en

PRODUCT DETAIL

Clarinase Repetabs

Code 64934
MA number 24/0163/95-S
Product Form: tbl plg 7x5 mg (blis.OPA/Al/PE/LDPE/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
MAH, country: Bayer, spol. s r.o., Slovakia
Therapeutic Class: 24 - ANTIHISTAMINICA, HISTAMIN
ATC:
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX13 Loratadine
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 05.04.1995
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
Dokument: DHPC_Pseudoefedrín_09.02.2024.pdf  
PIL: PIL_Clarinase Repetabs_05/2024.pdf  
SPC: SPC_Clarinase Repetabs_09/2024.pdf  
Safety feature Yes
Data update: 24.09.2024
eu-flag.png sk-flag.png